DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/tfwf37/topical_drug) has announced the addition of the "Topical Drug Delivery Partnering 2009-2014" report to their offering.
Topical Drug Delivery Partnering 2009-2014 provides understanding and access to the topical drug delivery partnering deals and agreements entered into by the world's leading healthcare companies.
The report provides a detailed understanding and analysis of how and why companies enter topical drug delivery partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors topical drug delivery technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.
This data driven report includes:
- Trends in topical drug delivery dealmaking in the biopharma industry since 2009
- Access to summary headline, upfront, milestone and royalty data
- Access to over 190 topical drug delivery contract documents
- The leading topical drug delivery deals by value since 2009
In Topical Drug Delivery Partnering 2009-2014, the available deals are listed by:
- Headline value
- Upfront payment value
- Royalty rate value
- Company A-Z
- Industry sector
- Stage of development at signing
- Deal component type
- Therapy type
For more information visit http://www.researchandmarkets.com/research/tfwf37/topical_drug